6CM
MBOT icon

683 Capital Management’s Microbot Medical MBOT Stock Holding History

683 Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Sell
170,000
-86,033
-34% -$192K 0.02% 198
2025
Q4 		$512K Buy
+256,033
New +$606K 0.02% 193

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

683 Capital Management's MBOT Position: Q1 2026 in Review

683 Capital Management reduced its Microbot Medical (MBOT) stake by 34% in Q1 2026, selling an estimated $192K and leaving 170,000 shares worth $410K. The position accounts for 0.02% of the portfolio, ranked #198.

683 Capital Management first reported a position in MBOT in Q4 2025 and has held it in 2 quarters since. The position peaked at $512K in Q4 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • 683 Capital Management held 170,000 shares of Microbot Medical worth $410K as of Q1 2026.
  • 683 Capital Management sold 86,033 Microbot Medical shares in Q1 2026, an estimated $192K.
  • Microbot Medical made up 0.02% of 683 Capital Management's portfolio in Q1 2026, its #198 holding.
  • 683 Capital Management first reported a position in Microbot Medical in Q4 2025 and has held it in 2 quarters since.
  • 683 Capital Management's Microbot Medical position peaked at $512K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.